drugs MODERATE Updated 2026-10-28

Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottle

See all recalls from Hikma Pharmaceuticals USA INC. →

Recalled Product

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Share this recall: Facebook X / Twitter WhatsApp Email

Hazard / Issue

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot #: 3047, Exp Date July 2027.

✅ What Should You Do?

  1. 1Stop taking this medication and contact your doctor or pharmacist immediately.
  2. 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
  3. 3Check the lot number on your bottle or packaging against the recalled lots listed above.
  4. 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
View official government recall